Overview: Total Protein Fluid TestIntroduction: The Total Protein Fluid Test measures total protein in body fluids to diagnose infections or inflammation. Following 2023 CAP guidelines, it uses biochemical methods for high specificity, supporting general screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected pleural or peritoneal effusions.
Other Names: Protein Body Fluids Assay, Fluid Protein Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Fluid protein testing began in the 1960s with effusion research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures total protein in body fluids to diagnose infections or inflammation, guides treatment, and evaluates patients with fluid accumulation.
Test Parameters: 1. Total Protein Level
Pretest Condition: No fasting required. Collect body fluid, pleural fluid, or peritoneal fluid. Report history of fluid accumulation or infection symptoms.
Specimen: Body Fluid (sterile container, 5-10 mL), Pleural Fluid (sterile container, 5-10 mL), Peritoneal Fluid (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fluid accumulation, fever, or history of infections/inflammation. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, infection/inflammation implications, and risks of sample collection.
Procedural Considerations: Uses colorimetric or turbidimetric methods to measure total protein levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for effusion diagnosis.
Factors Affecting Result Accuracy: Improper sample collection or contamination can affect results. Hemolysis may falsely elevate protein levels.
Clinical Significance: Elevated protein levels confirm infection or inflammation, guiding antibiotic or anti-inflammatory therapy. Normal levels may require further fluid analysis.
Specialist Consultation: Consult an internist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: Fluid cytology, LDH levels, or imaging to confirm infection/inflammation diagnosis.
Test Limitations: Non-specific for certain conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: CAP Fluid Analysis Guidelines, 2023; Archives of Pathology, Light RW, 2022.
